IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes
- PMID: 15565370
- DOI: 10.1007/s00125-004-1558-5
IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes
Abstract
Aims/hypothesis: Glutamic acid decarboxylase autoantibodies (GADA) are the most frequent beta-cell-specific autoantibodies in type 1 diabetes and in latent autoimmune diabetes in adults (LADA). The autoimmune attack on pancreatic islet cells is associated with a T helper 1 cell (T(h)1) response, mainly represented by IgG(1)-subclass in humans. It has been proposed that the presence of IgG(4) may be associated with a T(h)2 response. The aim of our study was to compare the GADA IgG-subclass distribution between adult patients with type 1 diabetes and LADA.
Methods: Patients with type 1 diabetes (n=45) and patients with LADA (n=60) were included. Radioimmunoprecipitation assay with IgG-subclass specific Sepharose (IgG(1), IgG(2), IgG(3) and IgG(4)) was used to precipitate the antibody/antigen-complex.
Results: We only detected IgG(4)-subclass of GADA in subjects with LADA (26.7%; p<0.001). IgG(1) was the most common GADA-subclass in both groups, however IgG(1) as the solely expressed subclass was more common among type 1 diabetic patients (77.8%; p<0.05). The rank order of the frequencies of IgG-subclasses in type 1 diabetes was IgG(1)>IgG(3)>IgG(2)>IgG(4) and in LADA patients IgG(1)>IgG(4)>IgG(2)>IgG(3).
Conclusions/interpretation: The difference in GADA IgG-subclasses could indicate a different immune response, possibly an altered balance between T(h)1 and T(h)2 cytokine profile in pancreatic islets. This difference could contribute to the slower rate of beta cell destruction in LADA patients, as reflected by a higher C-peptide level at clinical onset.
Similar articles
-
The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.Clin Exp Immunol. 2009 Aug;157(2):255-60. doi: 10.1111/j.1365-2249.2009.03939.x. Clin Exp Immunol. 2009. PMID: 19604265 Free PMC article.
-
Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.Chin Med J (Engl). 2003 Nov;116(11):1728-32. Chin Med J (Engl). 2003. PMID: 14642146
-
Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.Diabetes Metab J. 2020 Apr;44(2):260-266. doi: 10.4093/dmj.2019.0007. Epub 2019 Nov 12. Diabetes Metab J. 2020. PMID: 31769235 Free PMC article.
-
[Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].Arq Bras Endocrinol Metabol. 2008 Mar;52(2):315-21. doi: 10.1590/s0004-27302008000200019. Arq Bras Endocrinol Metabol. 2008. PMID: 18438542 Review. Portuguese.
-
LADA: A Type of Diabetes in its Own Right?Curr Diabetes Rev. 2019;15(3):174-177. doi: 10.2174/1573399814666180716150905. Curr Diabetes Rev. 2019. PMID: 30009711 Review.
Cited by
-
Latent Autoimmune Diabetes in Adults: Autoimmune Diabetes in Adults with Slowly Progressive β-cell Failure.Diabetes Metab J. 2012 Apr;36(2):116-9. doi: 10.4093/dmj.2012.36.2.116. Epub 2012 Apr 17. Diabetes Metab J. 2012. PMID: 22540047 Free PMC article. No abstract available.
-
The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.Clin Exp Immunol. 2009 Aug;157(2):255-60. doi: 10.1111/j.1365-2249.2009.03939.x. Clin Exp Immunol. 2009. PMID: 19604265 Free PMC article.
-
Identification of Sorafenib as a Treatment for Type 1 Diabetes.Front Immunol. 2022 Feb 15;13:740805. doi: 10.3389/fimmu.2022.740805. eCollection 2022. Front Immunol. 2022. PMID: 35242127 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical